Gut Registry

brand · release 2026-09-20

Invivo

Structured fields rendered from the release dataset. Unknown values retain a reason; price is outside GIS.

Formulations7
Conditional mean GIS54.73
Coverage42.9%

Axes 1–2 · Brand Index

Conditional score and coverage

Opacity share 14.3%. Brand results are not ordered when coverage bounds overlap. A brand-level sensitivity interval is undefined because the release preserves formulation-level intervals.

Axes 3–4

Measurement status and document panel

Not a measurement product, so this axis does not apply.

No brand review panel is published in this release.

Price column

Brand price aggregation

undefined: prices are retained at label-version level and are not averaged across formulations.

Brand profile

What this brand's labels look like as a set

Named strains
17 distinct designations printed across the 3 published products of this brand, compared without regard to letter case: W2, W21, W22, W23, W24, W25, W37, W51, W52, W54, W56, W57 …
Potency basis
The potency basis is not stated. 22 · counted across 22 organism rows on its labels, not across products
Forms
Powder: 3 · counted across the 3 of 3 products whose label states a form
Observed prices
0 of 3 published products
Printed claims per label
1.3 on average across the 3 of 3 products whose label carries a parsed claim block. A printed claim is not evidence and enters no axis.

Products

Published product pages of this brand

ProductGut Index Score
Invivo Bio.Me Barrier72.78
Invivo Bio.Me Femme UT49.20
Invivo Bio.Me Oral48.33

Organisms

What this brand actually puts on its labels

Across its published products, 25 distinct organisms or ingredients are printed. The most frequent, with the number of published products carrying each:

Organism or ingredientPublished products of this brand
Ligilactobacillus salivarius3
Ligilactobacillus salivarius W243
Bifidobacterium bifidum2
Bifidobacterium bifidum W232
Bifidobacterium lactis2
Lactiplantibacillus plantarum2
Lactiplantibacillus plantarum W212
Lacticaseibacillus casei2
Lacticaseibacillus casei W562
Lactobacillus acidophilus2
Bifidobacterium breve1
Bifidobacterium lactis W511
Enterococcus faecium1
Enterococcus faecium W541

Elsewhere in this release

Related pages

Findings computed over the whole corpus: Potency basis census · Supplier code network · Label designation changes

Tools: DSLD product check

Citation

Cite this page

Ivitskiy, I. (2026). Invivo. Gut Registry, release 2026-09-20. Elanvale Ltd. https://gutregistry.com/b/invivo/

The underlying tables are published under CC BY 4.0: this page as CSV · as JSON · full release and data dictionary. Cell-level provenance names the source record and its observation date.

Citable atoms

Release claims

  1. Invivo has 6 eligible SKUs and 7 formulation groups among labels in the NIH DSLD snapshot (Sep 2026).

    6 / 7 formulation groups · NIH DSLD snapshot Sep 2026 · brand.skus · checked 2026-09-20T00:00:00Z · snapshot b7633f732437

  2. 5 of 7 Invivo formulation groups have at least one printed strain designation (71.4%) in the NIH DSLD snapshot Sep 2026.

    5 / 7 formulation groups · NIH DSLD snapshot Sep 2026 · brand.naming · checked 2026-09-20T00:00:00Z · snapshot b7633f732437

  3. 1 of 7 Invivo formulation groups were scored using the available matching evidence (14.3%) in the NIH DSLD snapshot Sep 2026.

    1 / 7 formulation groups · NIH DSLD snapshot Sep 2026 · brand.opacity · checked 2026-09-20T00:00:00Z · snapshot b7633f732437

  4. Invivo: conditional Brand Index 54.73 from 3 of 7 formulation groups with numeric Gut Index Scores (42.9%); unscored groups remain outside the mean. Window: NIH DSLD snapshot Sep 2026.

    3 / 7 formulation groups · NIH DSLD snapshot Sep 2026 · brand.index · checked 2026-09-20T00:00:00Z · snapshot b7633f732437

Back to the release hub